Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhode Island Blood Center (RIBC) is the primary supplier of blood and blood products to hospitals throughout Rhode Island and southern New England. Established in 1979, the organization operates as a division of New York Blood Center Enterprises (NYBCe) and provides essential transfusion medicine services. RIBC's core activities include blood collection, laboratory testing, and the distribution of red cells, platelets, and plasma. Additionally, the center offers specialized clinical services such as therapeutic apheresis and supports biomedical research by providing high-quality human blood components for scientific study. The center plays a critical role in the regional healthcare infrastructure by ensuring a stable supply of life-saving blood products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhode Island Blood Center.